Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
N. M. Kuderer , T. K. Choueiri , D. Farmakiotis , B. I. Rini
Annals of Oncology 32 ( 6) 787 -800
183
2021
Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia.
R. Vyas , E. K. Gotow , J. L. DePry , H. M. Lazarus
Clinical and Experimental Dermatology 40 ( 8) 927 -929
2015
Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia
M W Harr , P F Caimi , K S McColl , F Zhong
Cell Death & Differentiation 17 ( 9) 1381 -1391
46
2010
Nivolumab before and after allogeneic hematopoietic cell transplantation.
F Covut , R Pinto , BW Cooper , B Tomlinson
Bone Marrow Transplantation 52 ( 7) 1054 -1056
13
2017
Multicenter Retrospective Study of Features and Outcomes of Patients with Intravascular DLBCL Treated at Academic Institutions within the United States
Philip S Boonstra , Paolo Caimi , Mark S Kaminski , Hashim Abbas
Blood 130 377 -377
2017
A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results
Anjali S Advani , Brenda W Cooper , Valeria Visconte , Paul Elson
Blood 130 150 -150
1
2017
Encouraging Early Results from the First in-Human Clinical Trial of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory B-Cell Lineage Non-Hodgkin Lymphoma
Kirit M Ardeshna , Paolo Caimi , Leonard Heffner , Erin Reid
Blood 130 187 -187
7
2017
Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era
Kay Ristow , Oscar Calzada , David A Bond , Jennifer Kelly Anderson
Blood 130 341 -341
1
2017
Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era
Suchitra Sundaram , Erika Moore , Sabarish Ayyappan , Fahrettin Covut
Blood 130 2775 -2775
1
2017
Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab (BR) for Follicular Lymphoma: A Real World Analysis Across 13 US Cancer Centers
Izidore S Lossos , James R. Cerhan , Thomas M Habermann , Andrew M Evens
Blood 130 2779 -2779
5
2017
A Phase II Study of Midostaurin and 5-Azacitidine for Elderly Patients with Acute Myeloid Leukemia
Molly M Gallogly , Ben K Tomlinson , Pam Bunner , Paolo Caimi
Blood 130 1332 -1332
4
2017
Treatment of Secondary Post-Transplant Engraftment Failure with Donor CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated By the Clinimacs® System
Paolo Caimi , Jane Reese , Merle Kolk , Robert Fox
Blood 130 1956 -1956
2017
Results from a Phase 1/2 Study of INCB050465, a Highly Selective and Highly Potent PI3Kδ Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies (CITADEL-101)
Andres Forero-Torres , Rod Ramchandren , Abdulraheem Yacoub , Michael S Wertheim
Blood 130 410 -410
2
2017
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
Andrew M Evens , Alexey Danilov , Deepa Jagadeesh , Amy Sperling
Blood 137 ( 3) 374 -386
3
2021
Early Cardiovascular Toxicity with Treatment of Follicular Lymphoma Is Associated with Shorter Overall Survival
Suchitra Sundaram , Gouri Dharmavaram , Benjamin K Tomlinson , Richard Creger
Blood 130 2776 -2776
2
2017
Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias
Naveed Ali , Brenda W Cooper , Merle Kolk , Richard Creger
Blood 130 5656 -5656
2017
Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
Fahrettin Covut , Jane Reese-Koc , Nausheen Ahmed , Patricio Rojas
Bone Marrow Transplantation 1 -4
2021
Low Dose Daily Corticosteroid Tapering Regimen Allows Highly Effective and Practical Desensitization for Multiple Myeloma Patients That Develop Skin Rash after Immunomodulatory Drugs
Paolo Caimi , Pingfu Fu , Marcos de Lima , Hannah Schmikla
Transplantation and Cellular Therapy 27 ( 3)
2021
Socioeconomic Factors and Survival of Multiple Myeloma Patients.
Leland Metheny , Paolo Caimi , Folashade Otegbeye , Pingfu Fu
Cancers 13 ( 4) 590
2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multi-center cohort study.
Izidore S Lossos , Veronika Bachanova , Neil Palmisiano , Narendranath Epperla
Haematologica
2
2021